Shandong Yumankun Biotechnology Co., Ltd.

Focus on medical science and technology for public health

See more +

Be realistic,Innovate,Responsibility,Multi-win

See more +

Become a leading technological and innovative pharmaceutical enterprise

See more +

scroll down

Into Yuman Kun

National high-tech enterprises, provincial specialized new small and medium-sized enterprises and have passed the ISO9001 quality management system certification.

Brief introduction of enterprise

The company is committed to new drug research and development and medical high-tech development, since its inception, has completed more than 30 scientific and technological achievements transformation
Click to enter
Production equipment

The company is committed to new drug research and development and medical high-tech development, since its inception, has completed more than 30 scientific and technological achievements transformation
Click to enter
Enterprise environment

The company is committed to new drug research and development and medical high-tech development, since its inception, has completed more than 30 scientific and technological achievements transformation
Click to enter
Honorary qualification

The company is committed to new drug research and development and medical high-tech development, since its inception, has completed more than 30 scientific and technological achievements transformation
Click to enter

2018

Company was established in 2018

3000

Has more than 3000 square meters of research and development center

Sales area covers 32 provinces and autonomous regions

30 honorary qualifications

Product display

The company is committed to new drug research and development and pharmaceutical high-tech development, since its inception, has completed the transformation of more than 30 scientific and technological achievements

News

Focus on medical science and technology, for the public health

More information content

Enterprise News

The corporate mission is the foundation of the company, which explains the value and significance of the company's existence; the company always regards drug research and development as the supporting force for the sustainable development of the company

Industry dynamics

The company implements strict quality audit and assessment, and comprehensively improves the pass rate of products leaving the factory.

News dynamics

Shandong Yumankun Biotechnology Co., Ltd. piracetam injection ninth batch of state procurement selected

On November 6, the ninth batch of national drug centralized volume purchasing meeting was held in Shanghai. Shandong Yumangkun Biotechnology Co., Ltd. consistency evaluation over the evaluation of the product piracetam injection was selected.

News dynamics

Good News｜Shandong Yumankun Biotechnology Co., Ltd. won the eighth batch of national centralized purchasing of pharmaceutical products.

News dynamics

Circular of the National Medical Security Bureau on Further Deepening the Intelligent Audit and Monitoring of the Medical Security Fund

Online Services

The company has a full service system from project research, synthesis process development, impurity preparation, preparation research, quality research, stability research, registration to obtain drug registration certificate and production technology guidance.

National high-tech enterprises, provincial specialized new small and medium-sized enterprises and has passed the ISO9001 quality management system certification.

Online message

National high-tech enterprises, provincial specialized new small and medium-sized enterprises and has passed the ISO9001 quality management system certification.